tiprankstipranks
BriaCell Therapeutics Corp (BCTX)
NASDAQ:BCTX
US Market
BCTX
BriaCell Therapeutics
RESEARCH TOOLSreports

BriaCell Therapeutics (BCTX) Income Statement

329 Followers

BriaCell Therapeutics Income Statement

Last quarter (Q2 2026), BriaCell Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q2, BriaCell Therapeutics's net income was C$-7.22M. See BriaCell Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jul 25Jul 24Jul 23Jul 22Jul 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -107.93KC$ 0.00C$ 0.00C$ 0.00C$ -15.55K
Operating Expenses
C$ 27.43MC$ 33.33MC$ 23.27MC$ 15.29MC$ 6.97M
Depreciation and Amortization
C$ 107.93KC$ 83.90KC$ 15.27KC$ 15.27KC$ 15.55K
EBITDA
C$ -27.43MC$ -4.85MC$ -23.26MC$ -26.82MC$ -7.10M
Operating Income
C$ -27.54MC$ -33.33MC$ -23.27MC$ -15.29MC$ -7.11M
Other Income/Expenses
C$ 656.60KC$ 28.40MC$ 2.97MC$ -11.55MC$ -6.84M
Pretax Income
C$ -26.88MC$ -4.93MC$ -20.30MC$ -26.84MC$ -13.82M
Net Income
C$ -26.63MC$ -4.79MC$ -20.30MC$ -26.84MC$ -13.82M
Per Share Metrics
Basic EPS
C$ -62.95C$ -43.68C$ -195.00C$ -259.50C$ -467.51
Diluted EPS
C$ -62.95C$ -43.68C$ -195.00C$ -259.50C$ -467.51
Weighted Average Shares Outstanding
 423.11K 109.70K 104.13K 103.29K 30.13K
Weighted Average Shares Outstanding (Diluted)
 423.11K 109.70K 104.13K 103.29K 30.13K
Currency in CAD

BriaCell Therapeutics Earnings and Revenue History